Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Glucagon-like peptide-1 receptor agonist treatment for pediatric obesity
Aaron S. Kelly
Pediatric Epidemiology & Clinical Research
Screening, Prevention, Etiology & Cancer Survivorship
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Glucagon-like peptide-1 receptor agonist treatment for pediatric obesity'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pediatric Obesity
100%
Receptor Agonist
100%
Agonist Treatment
100%
A1 Receptor
100%
Glucagon-like
100%
Pharmacotherapy
66%
Morbid Obesity
66%
Lifestyle Modification
66%
Obesity Medications
66%
Pediatric
33%
Obesity
33%
Weight Loss
33%
Effective Tool
33%
Pediatric Research
33%
Weight Loss Outcomes
33%
Poor Outcome
33%
Community Needs
33%
Pleiotropic Effects
33%
Medical Community
33%
Sufficient Evidence
33%
Glucagon-like peptide-1 Receptor (GLP-1R)
33%
Large Trials
33%
Obesity Drugs
33%
Successful Treatment
33%
Medicine and Dentistry
Childhood Obesity
100%
Drug Therapy
100%
Glucagon-Like Peptide-1 Agonist
100%
Adolescence
75%
Pediatrics
50%
Morbid Obesity
50%
Lifestyle Modification
50%
Disease
25%
Clinical Trial
25%
Pleiotropy
25%